Not all AD-associated genes were altered, indicating differences in genes whose expression change in response to amyloid plaque deposition and genes whose expression change in response to C5a–C5aR1 signaling, the latter of which may play an essential role in worsening AD cognitive performance. The gene discussed is C5; the disease is amyloidosis.